Breaking News

Frontage Labs Expands Early Phase Clinical Capabilities

Phase I clinical unit in Secaucus to conduct large scale Phase I and Bioequivalence studies and radiolabeled human AME research.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Frontage Labs

Frontage Clinical Services at 200 Meadowlands Parkway, Secaucus, NJ

Frontage Laboratories, Inc., a global Contract Research, Development and Manufacturing Organization (CRDMO), expanded its early phase clinical research capabilities across the U.S. and China. This expansion aims to enhance the company’s ability to support pharmaceutical and biotech partners with accelerated, high‑quality clinical development services. The company’s U.S. operations now include a 160‑bed, 36,000‑sq.‑ft. Phase I clinical unit in Secaucus, NJ, designed to conduct large‑scal...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters